Breaking News
Get 40% Off 0
🤯 Perficient is up a mind-blowing 53%. Our ProPicks AI saw the buying opportunity in March. Read full update
Close

Jubilant Pharmova Ltd (JUBA)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
679.00 -18.85    -2.70%
05:59:51 - Closed. Currency in INR ( Disclaimer )
Type:  Equity
Market:  India
ISIN:  INE700A01033 
S/N:  JUBLPHARMA
  • Volume: 190,951
  • Bid/Ask: 676.00 / 679.00
  • Day's Range: 675.50 - 704.55
Jubilant Pharmova 679.00 -18.85 -2.70%

Jubilant Pharmova Ltd Company Profile

 
Get an in-depth profile of Jubilant Pharmova Ltd, including a general overview of the company's business and key management, as well as employee data and location and contact information.
IndustryPharmaceuticals
SectorHealthcare
Employees

6000

Equity Type

ORD

Jubilant Pharmova Limited operates as an integrated pharmaceutical and life sciences company in India, the Americas, Europe, and internationally. It operates through six segments: Radiopharma, Allergy Immunotherapy, CDMO Sterile Injectables, Generics, Contract Research Development & Manufacturing Organisation (CRDMO), and Proprietary Novel Drugs. The Radiopharma segment offers radiopharmaceuticals products, which are used in the diagnosis and treatment of various diseases, including pulmonary embolism, cancer, coronary artery disease, and others. The Allergy Immunotherapy segment provides specialised diagnostic devices for skin testing, as well as venom immunotherapy products. The CDMO Sterile Injectables segment offers contract manufacturing services for sterile fill and finish injectables, liquids, ointments, creams, and ampoules. The Generics segment engages in the development, manufacturing, distribution, sale, and marketing of solid dosage formulations for therapeutic areas comprising cardiovascular system, central nervous system, gastrointestinal, and multispecialty. The CRDMO segment offers drug discovery and development services and active pharmaceutical ingredients. The Proprietary Novel Drugs segment develops therapies in the areas of oncology and auto-immune diseases. The company was formerly known as Jubilant Life Sciences Limited and changed its name to Jubilant Pharmova Limited in February 2021. Jubilant Pharmova Limited was incorporated in 1978 and is based in Noida, India.

Contact Information

Address 1A, Sector 16A
Noida, 201301
India
Phone 91 12 0436 1000
Fax 91 12 0423 4881

Top Executives

Name Age Since Title
Shyam Sunder Bhartia 69 1978 Chairman
Hari Shanker Bhartia 67 1982 Co-Chairman
Arvind Chokhany 51 2021 Group CFO & Whole-Time Director
Arjun Shanker Bhartia 36 2017 Joint MD & Director
Priyavrat Bhartia 47 2017 MD & Director
Jinang Pratap Parekh 42 2023 Whole-Time Director
Sushil Kumar Roongta 74 2017 Independent Non-Executive Director
Arun Seth 73 2018 Independent Non-Executive Director
Vivek Mehra 67 2017 Independent Non-Executive Director
Shirish Gundopant Belapure 71 2023 Additional Independent Non-Executive Director
Shivpriya Nanda 60 2024 Independent Director
Harsh Mahajan 65 2024 Independent Director
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

JUBA Comments

Write your thoughts about Jubilant Pharmova Ltd
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Paarth Shah
Paarth Shah Jul 15, 2021 5:27AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
why is this company receiving import alerts all the time?
Dipesh Prabhakar
Dipesh Prabhakar Apr 27, 2021 5:40AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
is it good for long term ?
Bull Runner
Bull Runner Oct 13, 2020 12:20PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Rakesh seems to be selling at every rise... never invest in a stock where big investors invest...
Mayank Parmar
Mayank Parmar Oct 13, 2020 10:45AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Why jubilant is so down now Don't understand the reason
Rajtilak Duggar
Rajtilak Duggar Oct 13, 2020 10:45AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Because of the Q1 poor results
Mayank Parmar
Mayank Parmar Oct 13, 2020 10:45AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Why jubilant is so down now Don't understand the reason
Mayank Parmar
Mayank Parmar Oct 13, 2020 10:44AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Why jubilant is so down now.? Don't understand the reason?
Mayank Parmar
Mayank Parmar Oct 13, 2020 10:44AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Why jubilant is so down now.? Don't understand the reason?
Mayank Parmar
Mayank Parmar Oct 13, 2020 10:44AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
why jubilant is so down now.? don't understand the reason?
Naresh Choudhury
Naresh Choudhury Aug 24, 2020 9:57PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
buy buy buyresult ahead
Aditya Bajaj
Aditya Bajaj Aug 24, 2020 12:13AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Buy Jubilan for target of 1000 plus
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email